Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | X014954 | — |
No additional adverse event reported; A HCP called to report the administration of an expired dose of MMR II (Lot: X014954 Expiration: 05/24/2025) that occurred on 05/28/2025. The HCP stated the patient did not experience any adverse issues or side effect from the expired administered do; This spontaneous report was received from a nurse and refers to a 1-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-May-2025, the patient started therapy with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #X014954, expiration date: 24-May-2025) 0.5 mL for an unknown indication. On 28-May-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported) (Expired vaccine used). No additional adverse event reported.
Sterile diluent